| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0B | $5.0B | $4.0B | $3.8B | $2.3B | $0.2B | $0.5B | $0.6B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.0B | $0.3B | $0.4B | $0.2B | $-0.2B | $0.1B | $0.1B |
| EPS (Basic) | $0.90 | $0.46 | $2.84 | $2.98 | $1.77 | $-1.81 | $0.83 | $1.25 |
| EPS (Diluted) | $0.89 | $0.45 | $2.80 | $2.93 | $1.75 | $-1.81 | $0.83 | $1.24 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.5B | $11.4B | $8.7B | $8.0B | $8.0B | $3.1B | $3.1B | $2.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.3B | $0.6B | $0.2B | $0.4B | $0.4B | $0.1B | $0.1B |
| Total Liabilities | $10.1B | $9.5B | $6.6B | $5.9B | $6.0B | $2.8B | $2.5B | $2.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.3B | $1.8B | $2.1B | $2.2B | $2.0B | $0.4B | $0.6B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.3B | $0.7B | $0.2B | $0.1B | $0.1B | $-0.2B |
| Investing Cash Flow | $-0.1B | $-1.6B | $-0.2B | $-0.1B | $-1.6B | $-0.0B | $-0.1B | $-0.1B |
| Capital Expenditures | $0.1B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.3B | $1.2B | $0.2B | $-0.8B | $1.6B | $0.3B | $-0.1B | $0.1B |